stars 1 stars 2 stars 3

BCD Innovations, Inc. develops novel methods for the prediction, detection, and treatment of cancer. We are dedicated to the commercialization of transformative approaches using patented genetic analysis technologies. BCD’s Plain Yard Test™ is a highly accurate molecular test for the diagnosis of bladder cancer that launched in the market this year.

BCD Innovations Questions

The BCD Innovations annual revenue was $5.2 million in 2026.

BCD Innovations is based in Baltimore, Maryland.

The NAICS codes for BCD Innovations are [621, 541, 54, 62].

The SIC codes for BCD Innovations are [8071, 873, 807, 87, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users